$38.99
0.451.17%
At Close: -
$38.74
-0.25-0.64%
After Hours: 8:43 AM EDT
15 minutes delayed
Calliditas Therapeutics
CALTNASDAQ
Calliditas Therapeutics (CALT) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCalliditas Therapeutics (NASDAQ:CALT) Stock Quotes, Forecast and News Summary
Calliditas Therapeutics Stock (NASDAQ: CALT) stock price, news, charts, stock research, profile.
| Open | $38.69 |
| Close | $38.99 |
| Volume / Avg. | 5.54K / 13.94K |
| Day Range | 38.68 - 39.00 |
| 52 Wk Range | 15.25 - 41.90 |
| Market Cap | $1.04B |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 64 |
| Short Interest | - |
| Days to Cover | 1 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Calliditas Therapeutics AB
Sector
Health Care
Industry
Pharmaceuticals
Calliditas Therapeutics AB is a commercial-stage biopharma company focused on identifying, developin...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Calliditas Therapeutics (CALT) stock?
You can purchase shares of Calliditas Therapeutics (NASDAQ:CALT) through any online brokerage.
Who are Calliditas Therapeutics (CALT) competitors?
Other companies in Calliditas Therapeutics’s space includes: GH Research (NASDAQ:GHRS), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE), Supernus Pharmaceuticals (NASDAQ:SUPN) and Tarsus Pharmaceuticals (NASDAQ:TARS).
What is the target price for Calliditas Therapeutics (CALT) stock?
There is no analysis for Calliditas Therapeutics.
What is the forecast for Calliditas Therapeutics (CALT) stock?
Calliditas Therapeutics has a consensus price target of $37.50.
Current stock price for Calliditas Therapeutics (CALT)?
The stock price for Calliditas Therapeutics (NASDAQ: CALT) is $38.74 last updated June 27, 2024 at 8:43 AM EDT.
Does Calliditas Therapeutics (CALT) pay a dividend?
There are no upcoming dividends for Calliditas Therapeutics.
When is Calliditas Therapeutics (NASDAQ:CALT) reporting earnings?
Calliditas Therapeutics’s Q2 earnings are confirmed for Thursday, August 15, 2024.
Is Calliditas Therapeutics (CALT) going to split?
There is no upcoming split for Calliditas Therapeutics.
What sector and industry does Calliditas Therapeutics (CALT) operate in?
Calliditas Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.